Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Blend Labs Inc (NYSE: BLND) was $3.31 for the day, down -1.49% from the previous closing price of $3.36. In other words, the price has decreased by -$1.49 from its previous closing price. On the day, 3.81 million shares were traded. BLND stock price reached its highest trading level at $3.35 during the session, while it also had its lowest trading level at $3.23.
Ratios:
Our analysis of BLND’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.21 and its Current Ratio is at 3.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 18, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $7.
On August 12, 2024, Canaccord Genuity Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $3 to $4.75.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 07 ’25 when Ling Winnie sold 15,000 shares for $3.74 per share. The transaction valued at 56,136 led to the insider holds 328,781 shares of the business.
Kneafsey Brian sold 30,000 shares of BLND for $111,819 on Jan 07 ’25. The Head of Revenue now owns 866,759 shares after completing the transaction at $3.73 per share. On Jan 07 ’25, another insider, Ling Winnie, who serves as the Officer of the company, bought 15,000 shares for $3.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLND now has a Market Capitalization of 859924736 and an Enterprise Value of 923853504. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.41. Its current Enterprise Value per Revenue stands at 5.895 whereas that against EBITDA is -15.595.
Stock Price History:
The Beta on a monthly basis for BLND is 1.42, which has changed by 0.46086955 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, BLND has reached a high of $5.53, while it has fallen to a 52-week low of $2.08. The 50-Day Moving Average of the stock is -26.78%, while the 200-Day Moving Average is calculated to be -3.55%.
Shares Statistics:
BLND traded an average of 2.90M shares per day over the past three months and 4071900 shares per day over the past ten days. A total of 252.13M shares are outstanding, with a floating share count of 208.21M. Insiders hold about 18.64% of the company’s shares, while institutions hold 43.40% stake in the company. Shares short for BLND as of 1734048000 were 7671220 with a Short Ratio of 3.82, compared to 1731628800 on 9294363. Therefore, it implies a Short% of Shares Outstanding of 7671220 and a Short% of Float of 3.2199999999999998.
